医学
肾
病理
肾脏疾病
发病机制
肾病
活检
肾功能
内科学
内分泌学
糖尿病
作者
Giorgio Trivioli,Elena Gelain,Maria Lucia Angelotti,Fiammetta Ravaglia,Marco Allinovi,Lorenzo Lodi,Leonardo Caroti,Annamaria Buccoliero,Giacomo Emmi,Marco Gattorno,Paola Romagnani,Stefano Volpi,Augusto Vaglio
标识
DOI:10.1053/j.ajkd.2022.05.008
摘要
Adenosine deaminase 2 (ADA2) deficiency is a rare autosomal recessive disease that is caused by loss-of-function mutations in the ADA2 gene. It is considered a monogenic form of polyarteritis nodosa and frequently is positive for a type I interferon (IFN) signature. Renal manifestations in ADA2 deficiency are poorly characterized. We herein report 2 cases of ADA2 deficiency with different kidney patterns due, respectively, to a predominantly macroscopic and microscopic vasculopathy, and review the literature on kidney disease in ADA2 deficiency. Patient 1 presented with a spontaneous perirenal hematoma; angiography demonstrated multiple microaneurysms but no further defects of the renal parenchyma; his kidney function remained normal. Patient 2 experienced slowly deteriorating kidney function and proteinuria. No major angiographic abnormalities were detected, while kidney biopsy revealed massive vasculopathy resembling chronic thrombotic microangiopathy (TMA) of the small and medium-sized vessels. Both patients had a positive peripheral type I IFN signature. In immunofluorescence staining of a kidney biopsy sample from patient 2, we observed marked expression of the type I IFN–induced protein MXA within endothelial cells, especially in vessels with TMA, and in infiltrating T cells. Our findings confirm that the kidney phenotype of ADA2 deficiency results from small and medium-sized vessel vasculopathy and suggest that type I IFN may be involved in the pathogenesis of kidney lesions.
科研通智能强力驱动
Strongly Powered by AbleSci AI